Medial septal β-amyloid 1-40 injections alter septo-hippocampal anatomy and function

Neurobiology of Aging

Volumn 31, Issue 1, 2010, Pages 46-57

  Colom, Luis V ^a,b   Castañeda, Maria T ^a   Bañuelos, Cristina ^a   Puras, Gustavo ^a   García Hernández, Antonio ^a   Hernandez, Sofia ^a   Mounsey, Suzanne ^a   Benavidez, Joy ^a   Lehker, Claudia ^a,b  

^a UNIVERSITY OF TEXAS AT BROWNSVILLE   (United States)

^b The Center for Biomedical Studies   (United States)

Author keywords

Amyloid; Cholinergic; GABAergic; Glutamatergic; Septo hippocampal; Septum

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ACETYLCHOLINE; AMYLOID BETA PROTEIN[1-40]; GLUTAMIC ACID;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN DYSFUNCTION; BRAIN FUNCTION; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; ELECTRIC POTENTIAL; HIPPOCAMPUS; HIPPOCAMPUS THETA RHYTHM; IMMUNOHISTOCHEMISTRY; INFORMATION PROCESSING; INTRACELLULAR RECORDING; MALE; NERVE CELL DEGENERATION; NERVE CELL STIMULATION; NERVE ENDING; NEUROANATOMY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

ACETYLCHOLINE; ACTION POTENTIALS; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; CHOLINERGIC FIBERS; DISEASE MODELS, ANIMAL; GLUTAMIC ACID; HIPPOCAMPUS; MALE; NERVE DEGENERATION; NEURAL PATHWAYS; NEURONS; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; SEPTAL NUCLEI; THETA RHYTHM;

EID: 70449524669     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2008.05.006     Document Type: Article

References (64)

1. Abe E., Casamenti F., Giovannelli L., Scali C., and Pepeu G. Administration of amyloid beta-peptides into the medial septum of rats decreases acetylcholine release from hippocampus in vivo. Brain Res. 636 (1994) 162-164
2. Andersen P., Bland H.B., Myhrer T., and Schwartzkroin P.A. Septo-hippocampal pathway necessary for dentate theta production. Brain Res. 165 (1979) 13-22
3. Bell K.F., Ducatenzeiler A., Ribeiro-da-Silva A., Duff K., Bennett D.A., and Cuello A.C. The amyloid pathology progresses in a neurotransmitter-specific manner. Neurobiol. Aging 27 (2006) 1644-1657
4. Bland B.H., and Colom L.V. Extrinsic and intrinsic properties underlying oscillation and synchrony in limbic cortex. Prog. Neurobiol. 41 (1993) 157-208
5. Bland B.H., and Oddie S.D. Theta band oscillation and synchrony in the hippocampal formation and associated structures: the case for its role in sensorimotor integration. Behav. Brain Res. 127 (2001) 119-136
6. Bland B.H., Oddie S.D., and Colom L.V. Mechanisms of neural synchrony in the septohippocampal pathways underlying hippocampal theta generation. J. Neurosci. 19 (1999) 3223-3237
7. Bland B.H., Declerck S., Jackson J., Glasgow S., and Oddie S. Septohippocampal properties of N-methyl-D-asparate-induced theta-band oscillation and synchrony. Synapse 61 (2007) 185-197
8. Brazhnik E.S., and Fox S.E. Intracellular recordings from medial septal neurons during hippocampal theta rhythm. Exp. Brain Res. 114 (1997) 442-453
9. Brazhnik E.S., and Fox S.E. Action potentials and relations to the theta rhythm of medial septal neurons in vivo. Exp. Brain Res. 127 (1999) 244-258
10. Brown D.R., and Kozlowski H. Biological inorganic and bioinorganic chemistry of neurodegeneration based on prion and Alzheimer diseases. Dalton Trans. (2004) 1907-1917
11. Butterfield D.A. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radic. Res. 36 (2002) 1307-1313
12. Caplan J.B., Madsen J.R., Schulze-Bonhage A., Aschenbrenner-Scheibe R., Newman E.L., and Kahana M.J. Human θ oscillations related to sensorimotor integration and spatial learning. J. Neurosci. 23 (2003) 4726-4736
13. + current in hippocampal CA1 pyramidal neurons. Biochem. Biophys. Res. Commun. 338 (2005) 1913-1919
14. Colom L.V. Septal networks: relevance to theta rhythm, epilepsy and Alzheimer's disease. J. Neurochem. 96 (2006) 609-623
15. Colom L.V., and Bland B.H. Medial septal cell interactions in relation to hippocampal field activity and the effects of atropine. Hippocampus 1 (1991) 15-30
16. Colom L.V., Castaneda M.T., Reyna T., Hernandez S., and Garrido-Sanabria E. Characterization of medial septal glutamatergic neurons and their projection to the hippocampus. Synapse 58 (2005) 151-164
17. Colom L.V., Diaz M.E., Beers D.R., Neely A., Xie W.J., and Appel S.H. Role of potassium channels in amyloid-induced cell death. J. Neurochem. 70 (1998) 1925-1934
18. Colom L.V., Garcia-Hernandez A., Castaneda M.T., Perez-Cordova M.G., and Garrido-Sanabria E.R. Septo-hippocampal networks in chronically epileptic rats: potential antiepileptic effects of theta rhythm generation. J. Neurophysiol. 95 (2006) 3645-3653
19. Davies P., and Maloney A.J. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2 (1976) 1403
20. Ekstrom A.D., Caplan J.B., Ho E., Shattuck K., Fried I., and Kahana M.J. Human hippocampal theta activity during virtual navigation. Hippocampus 15 (2005) 881-889
21. Francis P.T., Palmer A.M., Snape M., and Wilcock G.K. The cholinergic hypothesis of Alzheimer's disease: a review of progress. J. Neurol. Neurosurg. Psychiatry 66 (1999) 137-147
22. Garrido-Sanabria E.R., Perez M.G., Banuelos C., Reyna T., Hernandez S., Castaneda M.T., and Colom L.V. Electrophysiological and morphological heterogeneity of slow firing neurons in medial septal/diagonal band complex as revealed by cluster analysis. Neuroscience 146 (2007) 931-945
23. Giovannelli L., Casamenti F., Scali C., Bartolini L., and Pepeu G. Differential effects of amyloid peptides beta-(1-40) and beta-(25-35) injections into the rat nucleus basalis. Neuroscience 66 (1995) 781-792
24. Gonzalez I., Arevalo-Serrano J., Sanz-Anquela J.M., and Gonzalo-Ruiz A. Effects of beta-amyloid protein on M1 and M2 subtypes of muscarinic acetylcholine receptors in the medial septum-diagonal band complex of the rat: relationship with cholinergic, GABAergic, and calcium-binding protein perikarya. Acta Neuropathol. 113 (2007) 637-651
25. Gonzalo-Ruiz A., Sanz J.M., and Romero J.C. Activation of glial cells in an animal model of neuronal degeneration and its modulation by cholesterol and aging. Glia 1 Suppl. (2002) p. S23
26. Gonzalo-Ruiz A., Gonzalez I., and Sanz-Anquela J.M. Effects of beta-amyloid protein on serotoninergic, noradrenergic, and cholinergic markers in neurons of the pontomesencephalic tegmentum in the rat. J. Chem. Neuroanat. 26 (2003) 153-169
27. Gonzalo-Ruiz A., Perez J.L., Sanz J.M., Geula C., and Arevalo J. Effects of lipids and aging on the neurotoxicity and neuronal loss caused by intracerebral injections of the amyloid-beta peptide in the rat. Exp. Neurol. 197 (2006) 41-55
28. Gray C.W., and Patel A.J. Neurodegeneration mediated by glutamate and beta-amyloid peptide: a comparison and possible interaction. Brain Res. 691 (1995) 169-179
29. Hajszan T., Alreja M., and Leranth C. Intrinsic vesicular glutamate transporter 2-immunoreactive input to septohippocampal parvalbumin-containing neurons: novel glutamatergic local circuit cells. Hippocampus 14 (2004) 499-509
30. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002) 353-356
31. Harkany T., De Jong G.I., Soos K., Penke B., Luiten P.G., and Gulya K. Beta-amyloid (1-42) affects cholinergic but not parvalbumin-containing neurons in the septal complex of the rat. Brain Res. 698 (1995) 270-274
32. Henderson Z., Morris N.P., Grimwood P., Fiddler G., Yang H.W., and Appenteng K. Morphology of local axon collaterals of electrophysiologically characterised neurons in the rat medial septal/diagonal band complex. J. Comp. Neurol. 430 (2001) 410-432
33. Huerta P.T., and Lisman J.E. Heightened synaptic plasticity of hippocampal CA1 neurons during a cholinergically induced rhythmic state. Nature 364 (1993) 723-725
34. Hynd M.R., Scott H.L., and Dodd P.R. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem. Int. 45 (2004) 583-595
35. Jarvis K., Assis-Nascimento P., Mudd L.M., and Montague J.R. Beta-amyloid toxicity and reversal in embryonic rat septal neurons. Neurosci. Lett. 423 (2007) 184-188
36. Jerusalinsky D., Kornisiuk E., and Izquierdo I. Cholinergic neurotransmission and synaptic plasticity concerning memory processing. Neurochem. Res. 22 (1997) 507-515
37. Jones G.A., Norris S.K., and Henderson Z. Conduction velocities and membrane properties of different classes of rat septohippocampal neurons recorded in vitro. J. Physiol. 517 Pt 3 (1999) 867-877
38. Kohler C., Chan-Palay V., and Wu J.Y. Septal neurons containing glutamic acid decarboxylase immunoreactivity project to the hippocampal region in the rat brain. Anat. Embryol. (Berl.) 169 (1984) 41-44
39. Kumamoto E., and Murata Y. Excitatory amino acid-induced currents in rat septal cholinergic neurons in culture. Neuroscience 69 (1995) 477-493
40. Lee M.G., Chrobak J.J., Sik A., Wiley R.G., and Buzsaki G. Hippocampal theta activity following selective lesion of the septal cholinergic system. Neuroscience 62 (1994) 1033-1047
41. Leung L.S., and Shen B. Glutamatergic synaptic transmission participates in generating the hippocampal EEG. Hippocampus 14 (2004) 510-525
42. Leung L.W., Lopes da Silva F.H., and Wadman W.J. Spectral characteristics of the hippocampal EEG in the freely moving rat. Electroencephalogr. Clin. Neurophysiol. 54 (1982) 203-219
43. Liao M.Q., Tzeng Y.J., Chang L.Y., Huang H.B., Lin T.H., Chyan C.L., and Chen Y.C. The correlation between neurotoxicity, aggregative ability and secondary structure studied by sequence truncated Abeta peptides. FEBS Lett. 581 (2007) 1161-1165
44. Lynch G., Rose G., and Gall C. Anatomical and functional aspects of the septo-hippocampal projections. Ciba Found Symp. (1977) 5-24
45. Manseau F., Danik M., and Williams S. A functional glutamatergic neuron network in the medial septum and diagonal band area. J. Physiol. 566 (2005) 865-884
46. McGee A.W., and Bredt D.S. Assembly and plasticity of the glutamatergic postsynaptic specialization. Curr. Opin. Neurobiol. 13 (2003) 111-118
47. Morales F.R., Roig J.A., Monti J.M., Macadar O., and Budelli R. Septal unit activity and hippocampal EEG during the sleep-wakefulness cycle of the rat. Physiol. Behav. 6 (1971) 563-567
48. Nakamura S., Murayama N., Noshita T., Annoura H., and Ohno T. Progressive brain dysfunction following intracerebroventricular infusion of beta(1-42)-amyloid peptide. Brain Res. 912 (2001) 128-136
49. O'Keefe J. Hippocampus, theta, and spatial memory. Curr. Opin. Neurobiol. 3 (1993) 917-924
50. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. (1998), Elsevier
51. Pearson R.C., Sofroniew M.V., Cuello A.C., Powell T.P., Eckenstein F., Esiri M.M., and Wilcock G.K. Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase. Brain Res. 289 (1983) 375-379
52. Puma C., and Bizot J.C. Hippocampal theta rhythm in anesthetized rats: role of AMPA glutamate receptors. Neuroreport 10 (1999) 2297-2300
53. Puma C., Monmaur V., Sharif A., and Monmaur P. Intraseptal infusion of selective and competitive glutamate receptor agonist NMDA and antagonist D-2-amino-5-phosphonopentanoic acid spectral implications for the physostigmine-induced hippocampal theta rhythm in urethane-anesthetized rats. Exp. Brain Res. 109 (1996) 384-392
54. Rawlins J.N., Feldon J., and Gray J.A. Septo-hippocampal connections and the hippocampal theta rhythm. Exp. Brain Res. 37 (1979) 49-63
55. Santos-Torres J., Fuente A., Criado J.M., Riolobos A.S., Heredia M., and Yajeya J. Glutamatergic synaptic depression by synthetic amyloid beta-peptide in the medial septum. J. Neurosci. Res. 85 (2007) 634-648
56. Scali C., Prosperi C., Giovannelli L., Bianchi L., Pepeu G., and Casamenti F. Beta (1-40) amyloid peptide injection into the nucleus basalis of rats induces microglia reaction and enhances cortical gamma-aminobutyric acid release in vivo. Brain Res. 831 (1999) 319-321
57. Schliebs R. Basal forebrain cholinergic dysfunction in Alzheimer's disease-interrelationship with beta-amyloid, inflammation and neurotrophin signaling. Neurochem. Res. 30 (2005) 895-908
58. Selkoe D.J. Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann. N. Y. Acad. Sci. 924 (2000) 17-25
59. Simon A.P., Poindessous-Jazat F., Dutar P., Epelbaum J., and Bassant M.H. Firing properties of anatomically identified neurons in the medial septum of anesthetized and unanesthetized restrained rats. J. Neurosci. 26 (2006) 9038-9046
60. Sotty F., Danik M., Manseau F., Laplante F., Quirion R., and Williams S. Distinct electrophysiological properties of glutamatergic, cholinergic and GABAergic rat septohippocampal neurons: novel implications for hippocampal rhythmicity. J. Physiol. 551 (2003) 927-943
61. Vinogradova O.S. Expression, control, and probable functional significance of the neuronal theta-rhythm. Prog. Neurobiol. 45 (1995) 523-583
62. Whitehouse P.J., Price D.L., Struble R.G., Clark A.W., Coyle J.T., and Delon M.R. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215 (1982) 1237-1239
63. Winson J. Loss of hippocampal theta rhythm results in spatial memory deficit in the rat. Science 201 (1978) 160-163
64. Yoder R.M., and Pang K.C. Involvement of GABAergic and cholinergic medial septal neurons in hippocampal theta rhythm. Hippocampus 15 (2005) 381-392